Double treatment of severe hepatic veno-occlusive disease after allogeneic peripheral blood progenitor cell transplantation with recombinant tissue plasminogen activator

Thromb Haemost. 1997 Oct;78(4):1299-300.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Kidney Injury / drug therapy
  • Acute Kidney Injury / etiology
  • Female
  • Fibrinogen / analysis
  • Fibrinolytic Agents / therapeutic use*
  • Hematopoietic Stem Cell Transplantation*
  • Heparin / therapeutic use
  • Hepatic Veno-Occlusive Disease / drug therapy*
  • Hepatic Veno-Occlusive Disease / etiology
  • Humans
  • Leukemia, Myelomonocytic, Acute / therapy
  • Male
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • Recurrence
  • Thrombolytic Therapy*
  • Tissue Plasminogen Activator / therapeutic use*
  • Transplantation Conditioning / adverse effects
  • Transplantation, Homologous

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Fibrinogen
  • Heparin
  • Tissue Plasminogen Activator